Abiopharma

🔍 Listner Michael (Executive)

Company: Orange County Bancorp, Inc. /DE/ (OBT)

Report Date: 2026-03-19

Detailed Transactions and Holdings:

• Acquired 2,827 shares of Common Stock (Direct)
  Date: 2026-03-19 | Code: A | equity_swap_involved: 0 | shares_owned_after: 10,801.00 | transaction_form_type: 4 | Footnotes: F3, F1
• Sold 832 shares of Common Stock at $31.15 per share (Direct)
  Date: 2026-03-19 | Code: F | equity_swap_involved: 0 | shares_owned_after: 9,969.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Includes restricted stock units which vest at a rate of 1/3 per year commencing on March 21, 2025.
• F2: Includes restricted stock units which vest at a rate of 1/3 per year commencing on March 20, 2026.
• F3: Restricted stock units which vest at a rate of 1/3 per year commencing on March 19, 2027.